Zelira Therapeutics Ltd (ZLD) — Cash Flow Reinvestment Rate

Latest as of December 2015: 0.23x

Zelira Therapeutics Ltd (ZLD) has a Cash Flow Reinvestment Rate of 0.23x as of December 2015, reinvesting AU$36.80K (capex AU$36.80K ) from operating cash flow of AU$159.61K. Check ZLD cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.23x

(Capex + Investments) / Operating CF

Total Reinvested

AU$36.80K

Capex + Investments

Operating Cash Flow

AU$159.61K

AUD

Capital Expenditures

AU$36.80K

AUD

Zelira Therapeutics Ltd Cash Flow Reinvestment Rate (2011–2011)

Historical reinvestment intensity for Zelira Therapeutics Ltd across 1 annual periods. Explore ZLD long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Zelira Therapeutics Ltd (2011–2011)

Year-by-year capital reinvestment analysis for Zelira Therapeutics Ltd. For live market cap and broader valuation context, see ZLD company net worth.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2011	0.14x	AU$13.95K	AU$101.92K	AU$13.95K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow